| Also known as |
Galanthamine |
| Blood pressure |
Can cause hypotension or hypertension |
| Chemical name |
(4aS,6R,8aS)-5,6,9,10,11,12-Hexahydro-3-methoxy-11-methyl-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-ol |
| Dosage (medical) |
Typically 8 mg to 24 mg per day, taken in two divided doses |
| Dosage (sports) |
Not applicable |
| Effects |
Enhances cognitive function, improves memory and attention |
| Formula |
C17H21NO3 |
| Half-life |
Approximately 7 hours |
| Hepatotoxicity |
Low, but caution advised in patients with liver impairment |
| Lab Test |
Plasma levels can be monitored, though not routinely done |
| Main action |
Acetylcholinesterase inhibitor |
| Side effects |
Nausea, vomiting, dizziness, headache, and decreased appetite |
| Storage conditions |
Store at room temperature away from moisture and heat |
| Strength |
4 mg |
| Substance class |
Alkaloid |
| Trade name |
Razadyne, Reminyl |
| Use in sports |
Not typically used in sports |
| Water Retention |
Minimal |
| Manufacturer |
Sun Pharmaceuticals Industries |
